skip to main content

Products|Infectious diseases

The need for countries to be adequately prepared to respond quickly and effectively to future pandemics is more important than ever, as factors such as urbanization, global travel, trans-border trade and changes to the environment and food systems increase. Countries can face catastrophic consequences to populations and economies if their governments are not able to stop the rapid spread of infectious diseases. Infectious diseases (e.g, hepatitis, HIV/AIDS, measles, malaria, tuberculosis) are caused by pathogenic microorganisms and can be spread, directly or indirectly, from one person to another. Read our products below for evidence and insights about how the health system building blocks are used to provide care for infectious diseases.

COVID-19 living evidence profile #1: What is known about anticipated COVID-19 vaccine roll-out elements?

Living evidence profile:

View PDF - version 4 (updated 26 February 2021)

Living evidence profile:

View PDF - version 3 (updated 11 February 2021)

Living evidence profile:

View PDF - version 2 (updated 31 January 2021)

Living evidence profile:

View PDF - version 1 (updated 21 January 2021)

What do we know from both research and jurisdictional scans about prioritizing vaccination of asymptomatic residents in a long-term care home with an outbreak

Rapid evidence profile:

What is known about strategies for encouraging vaccine acceptance and addressing vaccine hesitancy or uptake?

Rapid evidence profile:

What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations

Rapid evidence profile:

What is known about whether vaccine injury-compensation programs and program elements affect vaccine acceptance and uptake

Rapid evidence profile:

What economic and social responses to COVID-19 have been evaluated in systematic reviews?

Rapid evidence profile:

What is the risk of transmission of COVID-19 in hospitals and long-term care homes, and the impacts of visitor policies in these settings?

Rapid evidence profile:

Which types of non-medical masks are effective in community settings for reducing the spread of COVID-19 for different populations and under different conditions?

Rapid evidence profile:

What evidence could support modeling scenarios related to the re-opening, operation and monitoring of schools?

Rapid evidence profile:

What provider-led virtual-care services can be used to replace in-person care in hospital-based ambulatory care settings?

Rapid evidence profile:

Assessing the Effectiveness of Virtual Care for Adults with Mental Health and/or Addictions Issues

Rapid synthesis:

What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19?

Rapid evidence profile:

Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular?

Rapid evidence profile:

What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively?

Rapid evidence profile:

What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions they should be tested?

Rapid evidence profile:

What is the evidence related to playground equipment and risk of COVID-19 transmission?

Rapid evidence profile:

What screening approaches can be used in non-healthcare settings (e.g., universities, stores and office settings) to identify people who may have COVID-19 and need to take appropriate action?

Rapid evidence profile:

How effective is temperature taking at borders or in general as a screening tool to identify people who may have COVID-19 and need to take appropriate action?

Rapid evidence profile:

What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action?

Rapid evidence profile:

What are the international lessons learned from re-opening non-COVID-19 activities in hospitals?

Rapid evidence profile:

What is known about strategies for supporting the use of masks under shortage conditions to prevent COVID-19?

Rapid evidence profile:

What are the most effective non-medical masks for preventing community transmission of COVID-19, and should they be required for all of society?

Rapid evidence profile:

What is known about the use of medical masks by essential non-medical workers to prevent community transmission of COVID-19?

Rapid evidence profile:

What is the evidence about and international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission?

Rapid evidence profile:

What is known about the spread and management of COVID-19 in non-health workplaces?

Rapid evidence profile:

What is known about approaches to and safety of conserving, re-using, and repurposing different kinds of masks?

Rapid evidence profile:

Enhancing the Delivery of Comprehensive Care for People Living with HIV in Canada

Citizen brief:

Citizen panel summary:

Evidence brief:

View PDF (English)View PDF (French)

Stakeholder dialogue summary:

View PDF (English)View PDF (French)

Video interviews:

Preventing and Managing Infectious Diseases Among People who Inject Drugs in Ontario

Citizen brief:

Citizen panel summary:

Evidence brief:

Stakeholder dialogue summary:

Video interviews:

The Pandemic Next Door: Complexities of a Global Outbreak Response

Video recording:

View

Strengthening National Health Systems' Capacity to Respond to Future Pandemics

Topic overview:

View PDF (English)View PDF (French)

Evidence brief:

View PDF (English)View PDF (French)

Stakeholder dialogue summary:

View PDF (English)View PDF (French)

Video interviews:

Addressing Housing Challenges Faced by People with HIV in Ontario

Topic overview:

Evidence brief:

Stakeholder dialogue summary:

Video interviews:

site by Cubicle Fugitive